Clearstead Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $373 | Sell |
378
-2,122
| -85% | -$2.09K | ﹤0.01% | 2513 |
|
|
2025
Q1 | $3.6K | Hold |
2,500
| – | – | ﹤0.01% | 1795 |
|
|
2024
Q4 | $5.5K | Hold |
2,500
| – | – | ﹤0.01% | 1698 |
|
|
2024
Q3 | $4.13K | Hold |
2,500
| – | – | ﹤0.01% | 1740 |
|
|
2024
Q2 | $5.55K | Hold |
2,500
| – | – | ﹤0.01% | 1668 |
|
|
2024
Q1 | $5.58K | Buy |
+2,500
| New | +$5.58K | ﹤0.01% | 1160 |
|